{"id":"F2006L00472","name":"Therapeutic Goods (Listing) Notice 2006 (No. 1)","slug":"therapeutic-goods-listing-notice-2006-no-1","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":117163,"registerId":"commonwealth-F2006L00472-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2006 (No. 1)","content":"![](image.001.png)\n\nTherapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2006 (No. 1)\n\nI, DAVID GRAHAM, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (ARTG) for listed goods:\n\n-   preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, for oral use that contain, as their therapeutically active ingredient, whole dried Undaria pinnatifida, excluding the holdfast, being a substance that is to be mentioned in Division 2 of Part 4 of Schedule 4 of the Therapeutic Goods Regulations 1990.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act this Notice ceases to have effect on the day that amendments to the Therapeutic Goods Regulations 1990 come into effect to require inclusion of the substance(s) listed in this Notice in the part of the ARTG for listed goods.\n\nDated this seventh day of February 2006\n\n(Signed)\n\nDr David Graham\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1808},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The Notice maintains a narrow, targeted scope limited to the temporary listing of a single specific therapeutic substance (Undaria pinnatifida). There is no evidence of scope expansion beyond the original administrative purpose of bridging a regulatory gap pending permanent legislative amendment."},"complexity_factors":["Single, highly specific substance definition with botanical exclusions (holdfast)","Temporary 'sunset' clause conditional on future amendments to underlying Regulations","Multiple nested cross-references to Schedule items and Divisions in the Regulations","Delegate authority framework under section 9A of the parent Act"],"plain_english_summary":"This notice temporarily allows oral preparations containing whole dried wakame seaweed (Undaria pinnatifida, excluding the holdfast) to be supplied in Australia as listed therapeutic goods, letting manufacturers, importers and retailers legally sell capsules, tablets or powders without prescription. It’s a temporary administrative measure that lasts only until the Therapeutic Goods Regulations are amended to permanently list the ingredient."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2006-no-1","history":"/api/acts/therapeutic-goods-listing-notice-2006-no-1/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2006-no-1/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2006-no-1/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2006-no-1/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2006-no-1/documents"}}